Main Hero Image

Pharmazz, Inc.

Pharmazz, Inc. is a clinical stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company is developing several clinical-stage product candidates, PMZ-2010, PMZ-1620 and PMZ-2123 for which it holds global marketing rights.

Established in 2010, Pharmazz Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop and market novel pharmaceutical products for use in critical care and hospital settings.


Agrochemicals Icon

PMZ 2010

Phase I Completed - Resuscitation Of Hypovolemic Shock and Post operative pain

Home and Garden Icon

PMZ 2123

Phase I - Brain edema in diabetic ketoacidosis

Pest Control Icon

PMZ 1620

Phase II Completed - Diagnostic imaging of solid tumor

Timber Treatment Icon

PMZ 1620

Phase I Completed - Neurovascular Neurogenesis and Angiogenesis

Status Of Products


Applications Research

In developing a formulation it is vital that scientists take into consideration how and where the finished product is to be used.

Formulations Research & Development

At Pharmazz, Inc. we pride ourselves on our ability to create innovative and exacting solutions that are tailored to customer’s ever evolving requirements.

Limited Environmental Impact

Clinical Trial Services

Pharmazz, Inc. is capable of providing services in Clinical Research, Regulatory Consulting, Data Management, Quality Management and Auditing, and more.